PHYSICIANS ARE IGNORING DTC DRUG ADS, STUDY CONCLUDES

Published Online: Thursday, March 1, 2007

The pharmaceutical industry's heavy spending on direct-to-consumer (DTC) drug advertising may not be paying off by increasing sales for the promoted products, reported researchers at the Medical University of South Carolina.

Although the study found that the television ads made patients more aware of medications such as Pfizer's Celebrex (celecoxib) and Merck's withdrawn drug Vioxx (rofecoxib), the researchers uncovered little evidence that physicians actually were prescribing more of the advertised drugs. The researchers called that finding good news, noting that it suggests that the effects of DTC advertising may not be as "pernicious" as many critics feared.




Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$
VSEO N/A